Ascidian Toxins with Potential for Drug Development

被引:33
|
作者
Watters, Dianne J. [1 ]
机构
[1] Griffith Univ, Sch Environm & Sci, Brisbane, Qld 4111, Australia
来源
MARINE DRUGS | 2018年 / 16卷 / 05期
关键词
secondary metabolites; bacterial symbiosis; anticancer activity; mechanism of action; MARINE NATURAL-PRODUCTS; TETRAHYDRO-BETA-CARBOLINES; LISSOCLINUM CF. BADIUM; ANTITUMOR-ACTIVITY; TOPOISOMERASE-I; CYCLIC-PEPTIDES; CANCER-CELLS; BISTRAMIDE-A; ACETYLCHOLINESTERASE INHIBITORS; ANTIPROLIFERATIVE ACTIVITY;
D O I
10.3390/md16050162
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Ascidians (tunicates) are invertebrate chordates, and prolific producers of a wide variety of biologically active secondary metabolites from cyclic peptides to aromatic alkaloids. Several of these compounds have properties which make them candidates for potential new drugs to treat diseases such as cancer. Many of these natural products are not produced by the ascidians themselves, rather by their associated symbionts. This review will focus mainly on the mechanism of action of important classes of cytotoxic molecules isolated from ascidians. These toxins affect DNA transcription, protein translation, drug efflux pumps, signaling pathways and the cytoskeleton. Two ascidian compounds have already found applications in the treatment of cancer and others are being investigated for their potential in cancer, neurodegenerative and other diseases.
引用
收藏
页数:33
相关论文
共 50 条
  • [21] The mosaic development of the ascidian egg
    Berrill, NJ
    BIOLOGICAL BULLETIN, 1932, 63 (03): : 381 - 386
  • [22] Venom Peptide Toxins Targeting the Outer Pore Region of Transient Receptor Potential Vanilloid 1 in Pain: Implications for Analgesic Drug Development
    Hwang, Sung-Min
    Jo, Youn-Yi
    Cohen, Cinder Faith
    Kim, Yong-Ho
    Berta, Temugin
    Park, Chul-Kyu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (10)
  • [23] Genetics of osteoarthritis and potential for drug development
    Loughlin, J
    CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (03) : 295 - 299
  • [24] Potential directions for drug development for osteoarthritis
    Roach, Helmtrud I.
    EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (05) : 475 - 486
  • [25] Metabolomics and its potential in drug development
    Beyoglu, Diren
    Idle, Jeffrey R.
    BIOCHEMICAL PHARMACOLOGY, 2013, 85 (01) : 12 - 20
  • [26] The Potential of the Cyclotide Scaffold for Drug Development
    Camarero, Julio A.
    Campbell, Maria Jose
    BIOMEDICINES, 2019, 7 (02)
  • [27] What is the potential of epigenetics in drug development?
    Lundstrom, Kenneth
    FUTURE MEDICINAL CHEMISTRY, 2015, 7 (03) : 239 - 242
  • [28] Toxins in Drug Discovery and Pharmacology
    Peigneur, Steve
    Tytgat, Jan
    TOXINS, 2018, 10 (03):
  • [29] MARINE TOXINS AS DRUG LEADS
    Botana, L. M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 11 - 11
  • [30] Exploring marine toxins: comparative analysis of chemical reactivity properties and potential for drug discovery
    Flores-Holguin, Norma
    Salas-Leiva, Joan S.
    Nunez-Vazquez, Erick J.
    Tovar-Ramirez, Dariel
    Glossman-Mitnik, Daniel
    FRONTIERS IN CHEMISTRY, 2023, 11